Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SERUM: Etanercept in RA
NCT01783015Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Sep 2013
- Primary completion
- Aug 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 7
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Sep 2013; status: terminated.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01783015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783015.